Literature DB >> 3160806

Dendritic cells that have interacted with antigen are targets for natural killer cells.

P D Shah, S M Gilbertson, D A Rowley.   

Abstract

Natural killer (NK) cells (poly I:C induced, x-ray resistant, nonadherent, Thy-1-, Ly-1.1-, Ly-2.1-, anti-asialo GM1-positive, and cytotoxic for YAC-1) suppressed T lymphocyte proliferation in mixed lymphocyte reaction (MLR) and autologous MLR cultures. Dendritic cells (DC) were required for proliferation of lymphocytes in both responses. The question whether lymphocytes or DC were the targets for NK cells was resolved by taking advantage of the fact that NK cells, but not DC, lose activity after 24 h in culture. Three findings indicate that DC, not lymphocytes, are targets for NK cells. First, responses suppressed by NK cells were fully restored by adding small numbers of DC to cultures 24 h after NK cells had been added. Second, DC incubated alone with NK cells and antigen for 24 h did not stimulate proliferation of lymphocytes. Third, lymphocytes incubated alone with NK cells for 24 h proliferated normally when DC were added. Additional experiments showed that DC became targets only after interaction with antigen. Thus, we suggest that NK cells may regulate lymphocyte proliferation by monitoring antigen presentation by DC.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160806      PMCID: PMC2187744          DOI: 10.1084/jem.162.2.625

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Delayed-type hypersensitivity to sheep red blood cells: inhibition of sensitization by interferon.

Authors:  J De Maeyer-Guignard; A Cachard; E De Maeyer
Journal:  Science       Date:  1975-11-07       Impact factor: 47.728

2.  Induction of interferon production in mouse spleen cell cultures by corynebacterium parvum.

Authors:  H M Hirt; H Becker; H Kirchner
Journal:  Cell Immunol       Date:  1978-06       Impact factor: 4.868

3.  Introduction of "natural" killer' cells by BCG.

Authors:  S A Wolfe; D E Tracey; C S Henney
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

4.  Modulation of the acquisition and expression of immunity by Tilorone: I. Delayed-type hypersensitivity responses.

Authors:  J R Kettman
Journal:  Immunopharmacology       Date:  1978-12

5.  The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.

Authors:  L A Holmberg; B A Miller; K A Ault
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

6.  In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice.

Authors:  S Habu; K Akamatsu; N Tamaoki; K Okumura
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

7.  Cell-mediated immunity: delayed-type hypersensitivity and cytotoxic responses are mediated by different T-cell subclasses.

Authors:  B Huber; O Devinsky; R K Gershon; H Cantor
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

8.  Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.

Authors:  J F Bukowski; J F Warner; G Dennert; R M Welsh
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

9.  Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release.

Authors:  K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

10.  Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.

Authors:  R J North; I Bursuker
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

View more
  35 in total

1.  Immunological studies of NK cell-deficient beige mice. II. Analysis of T-lymphocyte functions in beige mice.

Authors:  M E Baca; A M Mowat; D M Parrott
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

2.  NK cells inhibit T-cell responses: LFA3+ but not LFA3- T-cell responses are suppressed.

Authors:  P D Mason; G Lombardi; R I Lechler
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

Review 3.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 4.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

5.  Increased lymphokine activated killer (LAK) activity in the regional lymph nodes of mice following immunization with contact sensitizing agents.

Authors:  L Q Gao; G L Asherson; M Malkovsky
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

Review 6.  Lymphoid dendritic cells.

Authors:  J M Austyn
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

Review 7.  NK cells and their ability to modulate T cells during virus infections.

Authors:  Kevin D Cook; Stephen N Waggoner; Jason K Whitmire
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

8.  Purified human NK cells do not function as accessory cells in T-cell proliferative responses.

Authors:  O Silvennoinen
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

9.  Phenotypes and spontaneous cell cytotoxicity of mononuclear cells from patients with seronegative spondyloarthropathies: ankylosing spondylitis, psoriatic arthropathy and pauciarticular juvenile chronic arthritis--analysis of mononuclear cells from peripheral blood, synovial fluid and synovial membranes.

Authors:  J Thoen; O Førre; K Waalen; J Pahle
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

10.  Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis.

Authors:  A Ali; S Patterson; K Cruickshank; P Rudge; A G Dalgleish; S C Knight
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.